NOG Antikörper (AA 28-130) (Biotin)
Kurzübersicht für NOG Antikörper (AA 28-130) (Biotin) (ABIN908618)
Target
Alle NOG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 28-130
-
Kreuzreaktivität
- Maus, Ratte
-
Homologie
- Human,Dog,Cow,Sheep,Pig,Horse,Chicken,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Noggin
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- NOG (Noggin (NOG))
-
Andere Bezeichnung
- Noggin
-
Hintergrund
-
Synonyms: NOG, NOGG_HUMAN, Noggin, SYM 1, SYM1, Symphalangism 1 proximal, Synostoses multiple syndrome 1, SYNS 1, SYNS1.
Background: Inhibitor of bone morphogenetic proteins (BMP) signaling which is required for growth and patterning of the neural tube and somite. Essential for cartilage morphogenesis and joint formation. Inhibits chondrocyte differentiation through its interaction with GDF5 (PubMed:21976273).
-
Gen-ID
- 9241
-
UniProt
- Q13253
-
Pathways
- Stem Cell Maintenance, Tube Formation
Target
-